Features
- Naturally wettable silicone hydrogel material for unsurpassed comfort
- Daily disposable replacement
- UV blocker*
- Available in a complete family portfolio with asphere, Energys, toric and multifocal
- More prescription options than any other 1-day brand.5
Family products
With unsurpassed comfort,†‡§1-3 optimized design,4 unparalleled range,5 net plastic neutrality,|¶6 and the Simply Satisfied Guarantee™, when you choose MyDay®, you’ll make their day.
MyDay® Advantage: A Winning Family
Go ahead. Make MyDay®. High performance that will make your patients' day.4
MyDay® wins against the toughest competition!
UNBEATEN COMFORT†‡§1-3
UNBEATEN VISION§**††7-9
Unsurpassed Comfort4
Thanks to Aquaform® Technology, all MyDay® lenses are hydrated to twice their weight in water making them highly breathable and naturally wettable.4,6
Optimized Design
MyDay Energys® features DigitalBoost™ technology, an innovative, single-vision aspheric lens design that delivers a +0.3D boost, to help with eye tiredness and dryness associated with digital device use.4
MyDay® toric features Optimized Toric Lens Geometry™, the same technology found in Biofinity® toric, the #1 most prescribed toric lens on the market.10
MyDay® multifocal leverages CooperVision’s latest innovation in multifocal contact lens technology with the CooperVision Binocular Progressive System® to optimize vision for all levels of presbyopia and visual acuity at all distances.11 With its speed and ease of fit using OptiExpert®, you can successfully fit 98% of the time with two pairs or fewer.12,13
Unparalleled Range
MyDay® brand offers an unsurpassed number of prescription options across each lens design (asphere, Energys, toric and multifocal) compared to other 1 day SiHy brands.5
Net Plastic Neutral
The entire MyDay® portfolio is net plastic neutral due to our partnership with Plastic Bank.|¶6 Good for the Planet. Good for Business. Learn more.
Simply Satisfied Guarantee
When you prescribe the MyDay® family of lenses, we’re confident your patients will love them, but if they aren’t 100% happy, we’ll make it right—for you and for them. With our Simply Satisfied® Guarantee Program, your patients’ satisfaction is our guarantee.
*WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing googles or sunglasses because they do not completely cover the eye surrounding area. Persons should continue to use their protective UV-absorbing eyewear as directed.
† Vs. ACUVUE® OASYS MAX 1-Day, PRECISION1®, INFUSE® One-Day (US)/ULTRA® One-Day (ex-US).
‡ Vs. DAILIES TOTAL1® Multifocal & ACUVUE® OASYS MAX 1-Day MULTIFOCAL.
§ Vs. ACUVUE® OASYS 1-Day for ASTIGMATISM, PRECISION1® for Astigmatism & DAILIES TOTAL1® for Astigmatism.
| MyDay daily disposable orders includes MyDay Energys, MyDay daily disposable, MyDay daily disposable toric and MyDay daily disposable multifocal product(s) sold and distributed by CooperVision in the US.
¶ Net plastic neutrality is established by purchasing credits from Plastic Bank. A credit represents the collection and conversion of one kilogram of plastic that may reach or be destined for waterways. CooperVision purchases credits equal to the weight of plastic in MyDay daily disposable orders in a specified time period. MyDay daily disposable plastic is determined by the weight of plastic in the blister, the lens, and the secondary package, including laminates, adhesives, and auxiliary inputs (e.g. ink).
** Vs. DAILIES TOTAL1®, PRECISION1®, ACUVUE® OASYS MAX 1-Day, INFUSE® One-Day (US)/ULTRA® One-Day (ex-US).
†† Vs. DAILIES TOTAL1® Multifocal & ACUVUE® OASYS MAX 1-Day MULTIFOCAL at 2 weeks.
1. CVI data on file 2021 & 2023. MyDay® compared to PRECISION1® n=35 (dispense 9.1 vs 9.4 p=0.13, day 5 8.2 vs 8.4 p=0.39), INFUSE® One-Day/ULTRA® One-Day n=64 (dispense 9.3 vs 9.1 p=0.33, day 5 8.3 vs 8.7 p=0.13), ACUVUE® OASYS MAX 1-Day n=68 (dispense 93 vs 95 p=0.18, day 6 88 vs 91 p=0.06).
2. CVI data on file 2021 & 2023. MyDay® multifocal compared to DAILIES TOTAL1® Multifocal n=59 & ACUVUE® OASYS MAX 1-Day MULTIFOCAL n=56; no statistically significant differences (p>0.05) on dispensing, days 6 and 13 on application and throughout the day on days 6 and 13.
3. CVI data 2017, 2021 & 2023. MyDay® toric compared to ACUVUE® OASYS 1-Day for ASTIGMATISM n=20, PRECISION1® for Astigmatism n=47, DAILIES TOTAL1® for Astigmatism n=54; no statistically significant differences (p>0.05) at dispense & after 1 week daily wear on application and removal.
4. CVI data on file, 2024.
5. CVI data on file 2023. Based on prescription option combinations from available published sources (sph, cyl, axis, ADD) available across all SiHy daily disposable soft lenses in sph, toric and MF from CVI, JJV, B+L and Alcon in U.S. July 2023. Cosmetic CLs not included. Multiple base curve variants not included.
6. CVI Data on file, 2022.
7. CVI data on file 2015, 2021, 2023, and 2023. MyDay® clinical studies compared to DAILIES TOTAL1® n=22 (dispense -0.09 vs -0.10 p=0.624), PRECISION1® n=35 (dispense -0.14 vs -0.14 p=0.90, 1 week -0.14 vs -0.15 p=0.14), ACUVUE® OASYS MAX 1-Day n=68 (dispense -0.10 vs -0.11 p=0.22, 1 week -0.10 vs -0.10 p=0.25), and INFUSE n=64 (dispense -0.04 vs -0.04 p=0.79, 1 week -0.04 vs -0.04 p=0.54).
8. CVI data on file 2021 & 2023. MyDay® compared to DAILIES TOTAL1® Multifocal n=59 (day 13 far distance 2.10 vs 2.02 p=0.24, intermediate distance 2.03 vs 1.79 p=0.01, near distance 1.88 vs 1.54 p=0.001) & ACUVUE® OASYS MAX 1-Day MULTIFOCAL n=56 (insertion 91 vs 93 p=0.25, removal 86 vs 88 p=0.30).
9. CVI data on file 2017, 2021 & 2023. MyDay® toric compared to ACUVUE® OASYS 1-Day for ASTIGMATISM n=20, PRECISION1® for Astigmatism n=47, DAILIES TOTAL1® for Astigmatism n=54; no statistically significant differences in distance visual acuity (p>0.05) at dispense & after 1 week daily wear.
10. CVI data on file, 2023. US industry reports and internal estimates.
11. CVI data on file 2020. Prospective, double-masked, bilateral, 1-week dispensing study with MyDay daily disposable multifocal; n=104 habitual MFCL wearers.
12. CVI data on file 2020. Prospective, double-masked, bilateral, one-week dispensing study UK with MyDay® multifocal; n=104 habitual multifocal contact lens wearers.
13. CVI data on file 2021. Prospective, subject-masked, randomized, bilateral, two-week dispensing study at 5 US sites with MyDay® multifocal; n=58 habitual multifocal contact lens wearers.